Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review
Lucas Oliveira Maia, Yvan Beaussant, Ana Cláudia Mesquita Garcia
Journal of Pain and Symptom Management (2022) Vol. 63, Iss. 6, pp. e725-e738
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Are psychedelics the answer to chronic pain: A review of current literature
Nina Kooijman, Tim Willegers, Anke Reuser, et al.
Pain Practice (2023) Vol. 23, Iss. 4, pp. 447-458
Open Access | Times Cited: 25
Giving Consent to the Ineffable
Daniel Villiger
Neuroethics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Death Anxiety Among Users and Non-Users of Psychedelics
Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia, Everson Meireles, et al.
Journal of Psychoactive Drugs (2025), pp. 1-11
Closed Access | Times Cited: 1
Ayahuasca's therapeutic potential: What we know – and what not
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 28
Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?
Daniel Villiger
International Review of Psychiatry (2024), pp. 1-10
Open Access | Times Cited: 6
Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022
Xuepeng Jing, Nicholas Hoeh, David B Menkes
Palliative & Supportive Care (2023) Vol. 21, Iss. 4, pp. 697-704
Open Access | Times Cited: 14
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases
Sivan Schipper, Kabir Nigam, Yasmin Schmid, et al.
Cochrane library (2024) Vol. 2024, Iss. 9
Closed Access | Times Cited: 4
Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy
Erika Belitzky, Leonardo César Carvalho, Melissa V. Taylor, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review
Jennifer Bires
Journal of Psychosocial Oncology (2025), pp. 1-15
Closed Access
Ethical Considerations at the Intersection Between Psychedelic-Assisted Psychotherapy and Medical Assistance in Dying
Daniel Rosenbaum, Matthew Cho, Evan E. Schneider, et al.
AJOB Neuroscience (2023) Vol. 14, Iss. 2, pp. 139-141
Closed Access | Times Cited: 7
Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon
Val Bellman
Cancers (2024) Vol. 16, Iss. 9, pp. 1702-1702
Open Access | Times Cited: 2
The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey
Lisa Reynolds, Brian S. Barnett, Jeremy Weleff, et al.
Palliative & Supportive Care (2022) Vol. 22, Iss. 4, pp. 664-673
Open Access | Times Cited: 10
Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis
Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, et al.
Cancer (2023) Vol. 130, Iss. 7, pp. 1147-1157
Closed Access | Times Cited: 6
Exploring Psychedelics for Alleviating Existential and Spiritual Suffering in People With Serious Illnesses: Links to the Theory of Self-Transcendence
Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia, Pamela G. Reed
Journal of Holistic Nursing (2024)
Closed Access | Times Cited: 1
Contributions of the compassionate care approach to psychedelic-assisted therapies in hospice and palliative care
Ana Cláudia Mesquita Garcia, Myla Christie Araújo Custódio Bonifácio, Lucas Oliveira Maia
Progress in Palliative Care (2024) Vol. 32, Iss. 4, pp. 233-241
Closed Access | Times Cited: 1
What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study
Marianne Masse-Grenier, Sue-Ling Chang, Ariane Bélanger, et al.
Palliative & Supportive Care (2024), pp. 1-11
Open Access | Times Cited: 1
Expending Perspectives on the Potential for Psychedelic-Assisted Therapies to Improve the Experience of Aging
Yvan Beaussant, Kabir Nigam
American Journal of Geriatric Psychiatry (2022) Vol. 31, Iss. 1, pp. 54-57
Closed Access | Times Cited: 6
Commentary: Access to Psychedelics for Psychological Suffering at the End of Life – Prioritizing Our Priorities
Daniel Rosenbaum, Sarah Hales, Daniel Z. Buchman
Healthcare policy (2023) Vol. 18, Iss. 4, pp. 143-148
Closed Access | Times Cited: 3
Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy
Megan E. Miller, William E. Rosa, Alden Doerner Rinaldi, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 3, pp. 124-129
Open Access | Times Cited: 2
The Potential for Psychedelics to Improve Coping Skills and Resilience in Persons With Newly Diagnosed Mild Cognitive Impairment or Early Alzheimer’s Disease
Martin Steinberg, Paul B. Rosenberg, Albert Garcia‐Romeu
Current Geriatrics Reports (2023) Vol. 12, Iss. 3, pp. 149-155
Closed Access | Times Cited: 2
Psychedelic-Assisted Therapies in Patients With Serious Illness: Opportunities and Challenges
Michael Ljuslin, Kabir Nigam, Roxanne Sholevar, et al.
Psychiatric Annals (2022) Vol. 52, Iss. 9, pp. 359-364
Closed Access | Times Cited: 3
Examining the influence of team-based learning on medical students’ comprehension and attitudes regarding psychedelic therapies
Shiven Chaudhry, Anne Weisman, Molly M. Hagen, et al.
Dialogues in Clinical Neuroscience (2024) Vol. 26, Iss. 1, pp. 56-63
Open Access
Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives
Bushra Yasin, Shivani Mehta, George Tewfik, et al.
Exploration of neuroscience (2024) Vol. 3, Iss. 5, pp. 418-433
Open Access
Systematic Review of the Effect of Psychedelic-Assisted Therapy on Attitudes Toward Death, Life, and Spirituality on Symptoms of Distress, Depression, and/or Anxiety in Patients with Life-Threatening Illness
Thivya Turner, Paul Glue
Psychedelic Medicine (2024)
Closed Access
Registered Nurses' Knowledge and Attitudes Towards Psychedelics in Healthcare: Statewide Survey Results
Anna Graefe, Madison E. Weirick, Scott B. Harpin, et al.
Journal of Psychiatric and Mental Health Nursing (2024)
Open Access
Page 1 - Next Page

Scroll to top